Glenmark Pharma hits 52-week low on subdued Q4 results
The stock hit a fresh 52-week low of Rs 484, slipped 9% on the BSE in early morning trade, after the company reported 17% decline in its consolidated net profit at Rs 1.52 billion in March quarter.
No comments:
Post a Comment